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InﬂammasomesThe morbilliviruses are a closely related genus which are very similar in their sequences and share a common
receptor, but nevertheless show signiﬁcant restriction in the host species in which they cause disease. One
contribution to this restriction might be the nature of the hosts' responses to infection. We have used
microarrays to study the changes in the transcriptome of bovine dendritic cells after infection with wild-type
(pathogenic) and vaccine (apathogenic) strains of rinderpest virus (RPV), a bovine pathogen, and a wild-
type isolate of measles virus (MV), a morbillivirus that causes disease only in humans and some other
primates. We found that, as previously observed in human cells, MV induces a rapid interferon response,
while that induced by RPV was delayed and much reduced in magnitude. Pathogenic and apathogenic RPV
also showed signiﬁcant differences, with the latter inducing a slightly higher interferon response as well as
signiﬁcant effects on transcription of genes involved in cell cycle regulation.
© 2009 Elsevier Inc. All rights reserved.Introduction
The paramyxoviruses are a large group of viruses causing diseases
of many different species. The individual viruses normally only cause
disease in a limited range of hosts, although there are exceptions, such
as Canine distemper virus (CDV), which has a host range encompassing
many types of carnivorous mammal, including seals, lions and ferrets,
as well as domestic and wild dogs. More commonly, closely related
viruses exist which are each speciﬁc to a particular host, e.g. bovine
and human respiratory syncytial viruses. Our laboratory has been
actively investigating the determinants of pathogenicity of the
paramyxovirus Rinderpest virus (RPV), a member of the genus Mor-
billivirus and the causative agent of a highly contagious and often fatal
disease of cattle. RPV is also the most closely related virus to the
human pathogen Measles virus (MV). Indeed, it has been suggested
that MV came into human populations from RPV (Norrby et al., 1992);
it is assumed that an ancestral cattle morbillivirus passed to a human
host in which it could replicate inefﬁciently (but not necessarilyron).
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of transfer from one type of host to another is particularly important
given that both MV and RPV are the target of world-wide eradication
campaigns, which will lead to the relevant host populations
eventually having little or no acquired immunity to this group of
viruses, while other related viruses (e.g. CDV, Phocid distemper virus
(PDV), and Peste des petits ruminants virus (PPRV)) remain in
circulation. It is therefore important that a thorough understanding
is acquired of the interactions of these viruses with their respective
hosts and the underlying mechanisms of host-speciﬁcity of disease.
Although the morbilliviruses are restricted in the host range in
which they cause disease, they all seem able to infect most
mammalian species subclinically, at least enough to cause serocon-
version. These observations in vivo were explained in part by the
discovery that all morbilliviruses tested appear to use the highly
conserved protein CD150 (also known as signalling lymphocyte
activation molecule (SLAM)) as a primary receptor (Baron, 2005;
Seki et al., 2003; Tatsuo et al., 2001). This appears to give these
viruses a ready ability to enter and adapt to new hosts. In addition to
the example of RPV and MV already cited, sequence analysis has
shown that PDV was derived from CDV, or vice versa (Kovamees et
al., 1991). Forced passage of RPV in rabbits in an attempt to make an
attenuated virus for use as a vaccine resulted in a virus that was
indeed avirulent in cattle, but was now highly pathogenic in rabbits
(Yamanouchi et al., 1974). It is possible that, once MV and RPV have
been eradicated and immunisation stopped, another morbillivirus
224 S.K. Nanda et al. / Virology 395 (2009) 223–231may exploit the newly available set of hosts, giving rise to new
diseases, possibly severe.
Since individual morbilliviruses can infect many species, but cause
disease in few, the speciﬁc internal milieu of the infected host cell and
the response to viral entry may be critical in determining the outcome
of infection. The failure of MV to cause disease in cattle (and the
failure of RPV to cause disease in primates) may be determined by
differences in the ability of the viruses to use host cell components, or
differences in the host responses to the individual viruses. For
example, we have found that RPV can block both the induction
(Boxer et al., 2009) and the action (Nanda and Baron, 2006) of
interferons, and studies on a number of viruses have shown that the
ability to block innate immune responses can be a critical factor in
determining the pathogenicity of a virus (Bartlett et al., 2008; Devaux
et al., 2008; Huang et al., 2003; Parisien et al., 2002). If the abilities of
RPV and MV to control innate immune responses are host speciﬁc, or
otherwise different, this would affect host-speciﬁcity of pathogenesis.
We have determined the effects of RPV infection on bovine target
cells at the transcriptome level. In order to study whether host-
speciﬁcity of response to a virus is linked to host-speciﬁcity of disease,
we have compared not only host cell responses to infection with
virulent and avirulent RPV but also responses to virulent MV. The
results of these studies, coupled with previously published studies on
MV infection of human cells (Sato et al., 2008; Zilliox et al., 2006),
suggest that RPV and MV have fundamentally different ways of
combating host innate immune responses.Fig. 1. Principal component analysis of data from the microarray study. The log2 of the
average expression values (taken over all animals) for each gene in samples frommock-
infected cells or cells infected with MV, RPV-R (vaccine strain) or RPV-S (virulent
strain) were used for the analysis and the values of the ﬁrst two components (PC1 and
PC2) of the principal component analysis plotted. Numbers next to data points indicate
the hours post infection.Results
Viruses and target cells
The target cell for these studies had to be a bovine primary (non-
transformed) cell (since transformation often alters cell responses to
different stimuli) and one that was normally infected by RPV in the
host animal. We examined newborn calf oesopharyngeal cells (KOP-R
cell line) and primary monocyte-derived dendritic cells (moDCs),
since RPV and MV infect respiratory epithelial cells in vivo, while B
cells, T cells and DCs are major targets of RPV and MV in natural
infections. Both cell types could be infected by RPV or MV at N80%
when exposed to virus at a multiplicity of infection of 9–10, as
assessed by immunoﬂuorescence labelling of cells 16 h post infection
(data not shown). Immature DCs (including moDCs) are normally
considered as only expressing low levels of the morbillivirus receptor
(CD150/SLAM) (Murabayashi et al., 2002). In the absence of an
antibody recognising bovine CD150, we were unable to determine the
corresponding level of protein expression, but quantitative RT-PCR
showed that moDCs had a detectable level of CD150 mRNA, albeit 10-
fold lower than in activated cells (data not shown). CD150 mRNA
levels in the KOP-R epithelial cells were 600-fold lower than in
activated macrophages, and entry into these cells was probably
through an alternate receptor (Takeuchi et al., 2003). Since themoDCs
could be obtained frommultiple animals, they provided us with a way
of introducing biological replication into the experiment, and these
cells were therefore chosen for the target cells.
moDCs from six individual outbred cattle were infected with virus
(or treated with a similar volume of control preparation from B95a
cells). At 2, 4, 8 and 16 h post infection, cells were harvested and total
RNA prepared as described in Materials and methods. Poly(A)+ RNA
was ampliﬁed, labelled and hybridised to two kinds of arrays, a bovine
leukocyte cDNA array (BOTL5) and a bovine long oligo array (BLO)
(CAFG, Michigan). Although the results we obtained from the BOTL5
array mirrored those obtained from the BLO array, the variability of
the data from the former was much higher, and far fewer genes were
identiﬁed as differentially expressed. Most of the informative results
described below came from the BLO array data.Overall effects of infection
The LIMMA package can be thought of as performing a gene-by-
gene ANOVA (analysis of variance). In order to graphically represent
this analysis of variancewe used a data reduction technique (principal
component analysis (PCA)) which mathematically projects complex
multi-dimensional data (in this case the expression of N8000 genes in
each data set) onto two dimensions (Misra et al., 2002). In PCA the
dimensionality of the data set is reduced by replacing the original
variables (individual gene expression values) by a smaller number of
newly formed variables that are linear combinations of the original
variables while retaining the majority of the information about
(variation between) the data sets. The absolute values in the plot have
no direct physical correlates, rather they are a descriptive tool to
capture the relative degree of difference or similarity between the
data sets. While it is necessary to rely on the ANOVA analysis to
identify statistically signiﬁcant differences, the PCA gives a helpful
visual representation of the overall effects of infection on the
molecular state of host cells.
In the plot of the results of the PCA (Fig. 1), the ﬁrst principal
component (PC) (PC1, x-axis), representing the major amount (66%)
of the total variation between the data sets, appears to represent a
component of the transcriptional response over time which is
common to all experimental groups including the mock-infected,
since early time points are at one end of the axis and later time points
at the other. The second PC (PC2, y-axis), capturing 13% of the total
variation, appears to represent virus-induced molecular changes. We
observed that mock-infected cells followed a trajectory characterized
by a sharp transition along PC1 between an early (2–4 hpi) and a late
(8–16 hpi) infection state. The trajectory followed by cells infected by
the pathogenic strain of RPV (RPV-S) is shifted across the second PC
relative to that of the mock-infected cells, although overall they are
very similar to each other and, until the 16 hpi point, to cells infected
by the RPV vaccine strain (RPV-R). Cells infected with MV, on the
other hand, are characterized by an early transition across the second
PCwhich suggests a considerable response of the host toMV infection.
Our initial LIMMA analysis was aimed at identifying the different
factors that contributed signiﬁcantly to the overall variance of the data
so that all those factors should be included in the ANOVA. We found
that there were signiﬁcant variations in the gene-speciﬁc response in
different animals, so that there were statistically signiﬁcant differ-
ences in the expression of speciﬁc genes between different animals,
regardless of the treatment conditions (e.g. see Table II in Supple-
mental Materials for examples). This was not unexpected, given the
Fig. 2. Numbers of differentially expressed transcripts. Numbers of upregulated or downregulated transcripts identiﬁed by linear model analysis at each time point for each virus (a)
relative to mock infection and (b) relative to infection with other viruses. In each graph, the dark colours are the numbers of downregulated genes while the light colours are the
numbers of upregulated genes. “D.E. genes”=number of genes differentially expressed. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to
the web version of this article.)
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workingwithmultiple biological replicates. It was therefore necessary
to include animal as a factor in the ANOVA rather than simply average
over all biological replicates. We also found clear gene-by-dye effects,
as reported by others for two-channel data (Kelley et al., 2008; Liang
et al., 2003; Martin-Magniette et al., 2005) (see Table III in
Supplemental Materials). Our analysis therefore included treatment
(virus and time), animal and dye as factors, and these were the
coefﬁcients of the linear model ﬁtted by LIMMA. This model was then
used to determine the effects of speciﬁc virus/infection time on
individual genes (see Materials and methods). We compared virus-
infected cells at each time relative to mock-infected at the same times
(i.e. MV_2hpi vs Mock_2hpi, MV_4hpi vs Mock_4hpi, etc.). TheFig. 3. Comparison of the innate immune response to MV or RPV infection. (a) Interaction n
upregulated (red) or downregulated (green) in MV-infected cells at 4 hpi. The estimated log
having a statistically signiﬁcant change in expression. (b) The same network overlaid with
pattern except that no signiﬁcant change was identiﬁed for NCOA7 while CXCL10 and NM
deﬁned functional class of the gene product, as indicated in the legend.immediate results from this analysis were that the MV-infected cells
showed a much earlier and stronger response at the transcriptome
level than cells infected with RPV (Fig. 2a). Signiﬁcant changes in
transcription of several genes were seen in MV-infected cells at the
earliest time point (2 hpi), with more than a hundred genes showing
up/downregulation by 4 hpi. In contrast, no signiﬁcant change to the
level of any individual transcript was seen in RPV-infected cells until
8 hpi (Fig. 2a). RPV-R (vaccine strain) infection induced stronger/
earlier responses than RPV-S infection, but in neither case was there
any detectable change in transcription until 8 hpi. Cluster analysis of
the patterns of gene expression in virus-infected cells relative to
mock-infected showed similar results to that obtained by PCA on the
full data, in that the MV-infected cells clustered separately from theetwork (generated by IPA) of innate immune-related genes based on gene transcripts
2(fold change in expression level) relative to mock-infected cells is shown for each gene
the data for RPV-R-infected cells at 8 hpi. Cells infected with RPV-S showed a similar
I were upregulated. Genes are displayed using various shapes that represent the IPA-
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in pairs of the same time point, with the largest difference between
RPV-S and RPV-R at 16 hpi (Fig. S2 in Supplemental Materials). We
also compared the host response to each virus relative to the other
viruses (MV_2hpi vs RPV-R_2hpi, etc.; MV_2hpi vs RPV-S_2hpi, etc.;
RPV-R_2hpi vs RPV-S_2hpi, etc.) again showed the major differences
as being between MV and RPV (Fig. 2b). Differences between MV and
RPV-R were smaller at later times as the RPV-R-infected cells began to
respond. The complete sets of analysed data (virus vs mock and virus
vs virus) are available as Supplemental Materials.
Array data validation
To validate the results of the statistical analysis of the microarray
data, we selected a number of transcripts either identiﬁed as
signiﬁcantly up- or downregulated by LIMMA or which are regarded
as “housekeeping” genes (normally invariant) and created real-time
PCR pairs for the relevant bovine mRNA. Comparison of the relative
expression in the virus-infected samples as compared to the mock-
infected, as determined by LIMMA, with the difference in Ct (mock
minus virus) seen in real-time PCR showed a reasonably good ﬁt for all
genes tested (Fig. S3 in Supplemental Materials), in that all treatment-
time points identiﬁed as showing signiﬁcant up- or downregulation by
LIMMA showed the same change by real-time PCR. The absolute fold
changes determined by microarray analysis were smaller than those
determined by real-timePCR, aspreviously reported by others (Wang et
al., 2006; Yuen et al., 2002), and this led to some smaller changes in
transcription not being identiﬁed by the microarray analysis, but the
direction and timing of the effects were always correlated.
Effects of infection on transcription of speciﬁc genes
The lists of genes up- and downregulated by each virus at different
times, and the size and direction of change in expression, asTable 1
Transcriptional responses of IFN-responsive genes and genes associated with DC
activation and innate immune responses.
Gene name MV RPV-R RPV-S
BOLA-DMB 1.1501327 NS NS
BOLA-DQB 0.3271499 NS NS
CARD11 0.22852 NS NS
CCL3 1.2361403 NS NS
CD200 1.067258 NS NS
CD40 0.8104344 NS NS
CD83 0.8622541 NS NS
CSF1R −0.4019432 NS NS
CSF3 0.2317648 NS NS
GH 0.2433543 NS NS
IFI27 1.0259721 NS NS
IFI35 0.8819949 0.5279851 0.5328957
IFIH1 2.0319667 1.2292278 1.2140828
IL10 0.2751558 NS NS
IL18 1.5629684 NS NS
IL23A 0.2042142 NS NS
IRF9 0.3081433 0.3495631 NS
ISG20 1.7618855 0.7512296 0.963982
MSH2 −0.5418109 NS NS
MYD88 −0.1989387 NS NS
PARP9 0.5359386 0.5820352 NS
PSMB8 0.3486514 NS NS
PSMB9 1.7753032 0.8993551 0.9559519
PSME2 0.7497557 NS NS
TAP1 1.853143 1.0263434 1.0151106
TAP2 0.8709287 NS NS
TAPBP 0.3379066 NS NS
TLR3 0.7228488 NS NS
TNF 2.3677108 NS NS
The table shows the log2(fold change) in mRNA expression calculated from the
microarray data for a number of innate immune-related genes at 8 h after infectionwith
the indicated virus. NS = no signiﬁcant change.determined by LIMMA, were examined by functional module analysis
based on KEGG pathways, by comparisonwith canonical pathways, by
analysis of associated Gene Ontology (GO terms) and by construction
of networks of related genes (Ingenuity Pathway Analysis (IPA)). All
of these methods revealed the same biological processes occurring in
the infected cells. At 2 hpi, MV-infected cells showed upregulation of a
number of type-1 interferon-regulated genes (e.g. IFIT3 and IFIT5) and
other genes involved in innate immune responses (CCL2, XAF1 and
RGS16), as well as proteins that regulate other transcriptional
pathways (TRIM25 and CDKN2AIP). The activation of innate immune
responses was even more obvious at 4 hpi, with upregulation of a
number of interferon-responsive and other innate immune response
genes, as illustrated in the IPA-generated network in Fig. 3. In contrast,
RPV-infected cells did not show statistically signiﬁcant upregulation
of any individual gene until 8 hpi. The degree of activation of IFN-
stimulated and innate immune-related genes was lower in RPV-
infected cells at 8 hpi than that seen in MV-infected cells at 4 hpi (Fig.
3); responses to RPV-S were even lower than to RPV-R (Table 1).
These observations suggested that MV infection caused a rapid
induction of the type 1 interferon (IFN) response, while this response
wasmuch delayed in RPV infection. Since neither IFN-α nor IFN-βwas
represented on either array, we carried out real-time PCR assay of
bovine IFN-β mRNA in the samples to conﬁrm these observations
(Fig. 4). We found that IFN-β mRNA levels were already increased in
MV-infected cells relative to mock-infected cells at 2 hpi, rose to a
peak at 8 hpi and then declined, while the levels in RPV-infected cells
increased only at later times and never reached the same level as seen
in the MV-infected cells. As expected from the microarray analysis,
interferon mRNA levels were slightly higher in RPV-R-infected cells
than in RPV-S-infected cells.
In addition to the interferon response, MV-infected cells showed a
strong tumour necrosis factor (TNF) response, with TNF transcripts
being clearly upregulated at 8 hpi (Table 1, Fig. S2). The TNF
response may start earlier than this, as Gene Set Enrichment Analysis
(GSEA) showed similarities between the transcriptome response to
MV infection at 2 hpi and 4 hpi and that elicited by treatment of cells
with TNF, indicating some TNF secretion even at early time points.
MV-infected cells at 8 hpi showed increased transcription of a
number of apoptosis-related genes (e.g. caspases 1 and 8 (CASP1 and
CASP8), tumour necrosis factor (ligand) superfamily member 10
(TNFSF10/TRAIL), CD40 and various proteasome components)
(Fig. 5), which may be a response to the increased expression of
TNF. However, as moDCs functionally model many of the character-
istics of primary immature DCs, the increased expression of CD40 is
more likely to be a reﬂection of cellular activation/maturation, whileFig. 4. Quantiﬁcation of IFN-β mRNA in infected cells. Real-time PCR determination of
bovine IFN-β mRNA was performed on total RNA from virus-infected and mock-
infected cells as described in Materials and methods. The amount of mRNA in virus-
infected samples relative to that in mock-infected cells is expressed as the difference in
Ct values. Error bars represent the standard error of the difference in mean values
(mock minus virus-infected).
Fig. 5. Effect of MV infection on apoptotic genes. (a) The list of apoptosis-related genes showing altered expression in MV-infected cells at 8 hpi when compared to mock-infected
cells at the same time was used to construct a network of all genes/gene products having known interactions. The estimated log2(fold change in expression level) relative to mock-
infected cells is shown for each gene with colouring to indicate upregulated (red) or downregulated (green) transcripts. (b) The same network overlaid with the data for RPV-R-
infected cells at 16 hpi when compared to mock-infected cells at the same time. In RPV-S-infected cells at 16 hpi when compared to mock-infected cells at the same time, only TRAIL
showed signiﬁcant change (upregulated). Legend as Fig. 3.
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development of an inﬂammatory response, and possibly the
formation of activated inﬂammasomes. This inﬂammatory response
would lead to a block of apoptosis, and we did observe upregulation
of the apoptosis inhibitor baculoviral IAP repeat-containing 3 (BIRC3)as well as decreased transcription of a number of genes promoting
apoptosis (e.g. BAD, CAT and NOTCH2) (Fig. 5). Interestingly, RPV-
infected cells showed only limited effects on apoptosis-related genes
even at the latest timepoint used (16 hpi) (Fig. 5), despite the clear
induction of interferon in these cells. MV-infected cells also showed
228 S.K. Nanda et al. / Virology 395 (2009) 223–231early downregulation of components of the mitogen activated
protein kinase (MAPK) cascade and, by 8 hpi, downregulation of
transcripts for RNA polymerase I and II components and proteins
involved in cell cycle control (e.g. CCND3 (cyclin D3), CDK4 (cyclin-
dependent kinase 4), MAPK14, SEPT4 (septin 4) and CDC23 (cell
division cycle 23 homologue)), observations not made on cells
infected with RPV.
Direct comparison of MV infection with RPV infection showed
primarily the expected differences arising from the different cytokine
responses, in particular the difference in type 1 IFN induction. Relative
to RPV infection, MV-infected cells also showed downregulation of
genes from a number of metabolic pathways (e.g. glutathione
metabolism, fatty acid biosynthesis and glycolysis) and upregulation
of genes of the inositol phosphate metabolism pathway. Comparison
of the responses to infection by vaccine or virulent RPV was more
difﬁcult due to the smaller number of genes showing individual
signiﬁcant changes in transcription level. GSEA, in which patterns of
change in multiple genes are analysed (Subramanian et al., 2005), is
more useful in such cases. Comparison of RPV-R and RPV-S using GSEA
showed, in addition to the effects of the slightly higher IFN levels in
RPV-R infection, that RPV-R infection induced a relative upregulation
of cell cycle regulator proteins, and downregulation of genes
controlling cell proliferation. Genes expressed at lower levels in
RPV-R infected cells, relative to RPV-S-infected cells, at 8 and 16 hpi
resembled the pattern of downregulation induced by overexpression
of p21/CDKN1a (cyclin-dependent kinase inhibitor 1A), suggesting
that RPV-R sends infected cells into p53-mediated G1 arrest.
Interestingly, this pattern was not seen in MV-infected cells.
The observed differential cytokine induction would have been
expected to have a signiﬁcant effect on viral replication. Since the
length of the timecourse was insufﬁcient to allow new virions to
accumulate, we measured viral RNA transcription, speciﬁcally the
levels of viral nucleocapsid (N) protein mRNA, as an indicator of viral
replication. Real-time PCR of RPV and MV NmRNA levels showed that
all three mRNAs were already present in quite high amounts at 2 hpi
for all viruses (Fig. 6). The effect of the induction of innate immune
responses by MV could be seen by the fact that MV N mRNA levels
failed to increase further over the following 14 h, whereas N mRNA
levels for both strains of RPV show a second increase at around 8 hpi,
representing either transcription from newly synthesised genome, a
process that takes at least 3 h even under optimal conditions and with
plentiful supply of viral proteins (Gubbay, Curran, and Kolakofsky,
2001) or increased transcription arising due to de novo synthesised
viral polymerase (Plumet et al., 2005).Fig. 6. Quantiﬁcation of viral mRNA. Nucleocapsid protein mRNA for RPV-S, RPV-R or
MV was determined by real-time RT-PCR using speciﬁc primer pairs as described in
Materials andmethods and expressed as the difference between the observed Ct and 40
(total number of cycles used) in order to make increases in mRNA levels lead to an
increase in graphed value. Error bars show one standard deviation of the measured
values.Discussion
DCs are immune cells unique in their ability to initiate host innate
and adaptive immune responses. They are distributed throughout the
tissues of the host, forming a continuous network of sentinels
detecting invading pathogens. They are likely to be one of the ﬁrst
cells encountered by either RPV or MV, and certainly the ﬁrst type of
cell encountered that carries the RPV/MV receptor CD150. Due to DCs'
critical role in the immune response, many viruses have evolved
complex mechanisms for subverting or altering DC functions in order
to promote the pathogen's survival. The direct interactions of viruses
with DCs are fundamental to understanding viral pathogenicity and
its relationship to host responses. The growth of MV in various types
of DC and the roles of DCs in MV pathogenicity and virus spread has
been studied by several groups (recently reviewed in Hahm (2009)).
Transcriptome analyses permit examination of the host response at
the level of a speciﬁc cell type; in the particular case of DCs, useful
inferences can be made about the nature of the ensuing immune
response in the host itself.
Comparison of the response of the bovine moDCs to infection
with virulent and avirulent RPV suggests that one of the main
differences is in the strength of the type 1 IFN response. This ﬁnding
agrees with studies in both animals and primary cell culture which
suggested that virulent RPV induced a weaker IFN response than
attenuated virus strains (el-Zein and Srour, 1985; Hussain et al.,
1982) and also with our more recent ﬁndings in cell culture which
showed that the non-structural C protein of RPV-S is more effective
than that of the vaccine strain RPV-R at inhibiting IFN induction, and
in consequence that RPV-R activates transcription from the IFN-β
promoter more than does RPV-S (Boxer et al., 2009). The ability of a
strain of RPV to block the induction of interferon, whether in primary
cells or cell lines, is not an absolute guide to virulence, however,
since the wild-type ancestor of the RPV-R vaccine strain causes
essentially 100% mortality in cattle yet induces signiﬁcant amounts
of interferon in cell culture (Boxer et al., 2009). This may be because
the overall type 1 IFN response in the host is largely governed by IFN
production in plasmacytoid DCs (pDCs), and so the responses of
conventional DCs, or any of the other cell types used in these and
related studies, are only a limited guide to the overall innate immune
response in the host and hence the outcome of infection. While there
is as yet no marker for bovine pDCs allowing their puriﬁcation, it
would be of interest to see a comparison of the effects of MV
infection on transcription in human pDCs with the results from the
existing studies (Zilliox et al., 2006; Sato et al., 2008).
The response of the bovine moDCs to MV infection throws up
several interesting questions. At ﬁrst glance it seems as if the
replication of MV in cattle is blocked purely because the virus induces
a strong innate immune response in bovine cells. However, a previous
study on the effect of wild-type MV on transcription in human
monocytes showed an almost identical rapid induction of IFN-β
(Zilliox et al., 2006), showing that the effect of wild-type MV on
bovine and human cells is similar. A separate studywith another wild-
type MV isolate showed the same rapid innate immune response in
the human embryonic kidney cell line 293 (modiﬁed to express the
MV receptor CD150/SLAM) (Sato et al., 2008). In the latter study, a
cell line derived from human cord blood (COBLa) did not show the
same stimulation of the innate immune response when infected with
MV; however, the ability of those cells to produce interferon in
response to cytoplasmic dsRNA or other viral RNAwas not shown, and
they may represent a cell type unresponsive to these stimuli. Other
studies suggest that the cell type may also be critical in determining
the type 1 IFN response to MV. In a study using peripheral blood
lymphocytes speciﬁcally free of monocyte-lineage (adherent) cells
(Naniche et al., 2000), wild-type MV induced less IFN than vaccine
strains, and suppressed IFN production induced by secondary
infection with an MV vaccine strain.
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responses to MV infection in human cells, the virus stocks were
passed in cell culture several times before use, if only to create a virus
stock for use in the infection studies. It may well be that even this
limited passage alters the virus. The response to wild-type MV
infection seen by us and others was similar to what might have been
expected if the virus stocks had a high content of DIs. As described in
Materials and methods, we took particular care to prevent DIs from
accumulating, and the almost constant virus titre at each passage
suggested no signiﬁcant accumulation of DIs. We also looked for
growth suppression interference by our MV stock in a mixing
experiment (Whistler et al., 1996). MV DI would be expected to
interfere equally with MV or with RPV since MV promoters are
replicated as well as RPV promoters by RPV proteins (Baron and
Barrett, 1997; Brown et al., 2005). When we mixed the MV stock with
RPV-S stock (which clearly did not have a signiﬁcant DI content, given
the minimal response to RPV-S infection seen in the moDCs), no
reduction in virus yield was seen (data not shown). Similarly, the
other studies which showed strong interferon responses to wild-type
MV (Sato et al., 2008; Zilliox et al., 2006) took pains to prevent DI
accumulation in their virus stocks.
The data from our studies comparing RPV and MV, combined
with the other studies on MV alone, indicate a fundamental
difference between RPV and MV. The second major observation in
these studies was the greatly delayed response to RPV infection in
the DCs. DCs are functionally adapted to mount an immediate
response to infection whether by viral or bacterial pathogen. The
rapid transcriptional response induced by MV is what might
normally be expected. The observation that the transcriptional
responses in RPV-infected cells did not reach detectable levels until
N4 hpi suggests that RPV is blocking/inhibiting such responses in an
active way, and that MV does not have the same blocking
mechanism. Having established that it is the non-structural proteins
of RPV that separately control interferon action and induction (Boxer
et al., 2009; Nanda and Baron, 2006), we are also studying the ability
of the non-structural proteins of the MV isolate used in these studies
to affect interferon action and/or induction, since the response of
the moDCs to infection by these viruses suggests that there are real
differences in the way these proteins work. The RPV C protein blocks
IFN induction at a point downstream of interferon regulatory factor
3 (IRF3) activation (Boxer et al., 2009), and can therefore block the
induction of IFN whether it occurs via the cytoplasmic pathogen
recognition receptors such as retinoid inducible gene 1 (RIG-I) or via
extracytoplasmic receptors such as Toll-like receptors (TLRs) (Boxer,
E.L. and Baron, M.D., unpublished). Since RPV C appears to interfere
with the activity of both IRF3 and NF-kB (Boxer et al., 2009), it may
be inhibiting a range of transcriptional responses in addition to the
effect on IFN induction. The C protein of the MV used in these
studies blocks IFN induction induced by cytoplasmic dsRNA, but not
that which is induced via TLRs (Boxer, E.L. and Baron, M.D.,
unpublished), so the mechanisms involved appear to be fundamen-
tally different. RPV has evolved mechanisms to suppress IFN
induction by a number of different pathways, while MV seems to
have adopted a strategy that allows it to replicate, in humans at
least, in the face of a strong type 1 IFN response in at least some cell
types (Sato et al., 2008; Zilliox et al., 2006). Such a difference in
strategy would have implications for the risk of MV crossing into
animal populations, or the risk of animal morbilliviruses crossing
into human populations if MV is eradicated and vaccination stopped.
If MV and RPV used the same strategy to cope with their hosts'
innate immune responses, the barrier to humans being pathogeni-
cally infected by RPV or PPRV might only be the need for a mutation
in one viral protein to allow it to ﬁt better with the same target
protein in the new host, a relatively low barrier for an RNA virus. If
the viruses have had to evolve different strategies to cope with
(possibly subtle) differences in their hosts' different innate immunesystems, then there is a much higher barrier preventing one virus
from causing disease in another host.
Further work is needed to determine the mechanism of stimula-
tion of the innate immune responses in the case of MV. The
intracellular response to MV infection has been ascribed to melanoma
differentiation associated protein-5 (mda-5) (Berghall et al., 2006) or
to RIG-I (Plumet et al., 2007); wild-type MV has also been reported as
speciﬁcally activating the TLR2-dependent signalling pathway (Bie-
back et al., 2002), which leads to an inﬂammatory response as seen
here. Inﬂammatory responses have been seen in other cell types
infected with wild-type MV and localised inﬂammatory responses are
thought to be associated with the encephalitis associated with some
MV infections (Ghali and Schneider-Schaulies, 1998; Patterson et al.,
2003), although MV seems not to generate a systemic inﬂammatory
response (Devaux et al., 2008). It is clearly important to determine the
effects of these viruses on the full range of immune effector cell types,
particularly on pDCs.
Materials and methods
Virus growth and puriﬁcation
The virus strains used in this study were (a) the Saudi/81 strain of
RPV, which causes 100% mortality in cattle (RPV-S), used at the 4th
passage from a sample of spleen from an animal infected with RPV-S
and used as an example of a wild-type, highly pathogenic strain of this
virus; (b) the “Plowright” vaccine strain of RPV, which is an
apathogenic, non-secreted strain derived by tissue culture passage
(RPV-R) and used at the 4th passage after recovery from a full-length
cDNA (Baron and Barrett, 1997); and (c) an isolate of MV from the
2000 outbreak of measles in Dublin, derived from a tissue sample of a
patient with severe measles (a kind gift from Dr P. Duprex, Queen's
University, Belfast), used at the 9th passage after receipt as the
original isolate was heavily contaminated with mycoplasma and was
therefore grown through three rounds of treatment (6 passages) with
BM-cyclin (Merk) before a stock was grown for use. The titre of the
virus stock was measured at each passage and remained between 105
and 106, indicating that the MV stock did not have signiﬁcant
contamination with defective interfering particles (DIs) (Whistler,
Bellini, and Rota, 1996). All working stocks of virus were grown in the
marmoset B-cell line B95a, which has previously been shown to be a
good host for wild-type morbilliviruses (Kobune et al., 1991) and to
prevent accumulation of DIs (Shingai et al., 2007). Virus was puriﬁed
from soluble factors that might contribute to the host cell response by
precipitation with polyethylene glycol (PEG) (Trepanier et al., 1981).
Final virus titre was determined as 50% tissue culture infectious dose
(TCID50) on B95a cells. As a further control, mock-infected B95a cells
were processed as for virus puriﬁcation and the resultant PEG
precipitate used to ‘infect’ cells (“Mock” samples).
Preparation and infection of moDCs
Monocyte-derived dendritic cells (moDCs) were prepared as
described (Werling et al., 1999) from fresh blood from Holstein–
Friesian stock animals. Cells (approx 105 per well in 12-well plates)
were infected with virus at a multiplicity of infection (m.o.i.) of 10 for
1 h in a ﬁnal volume of 0.5 ml. Virus was then removed, cells washed
once with medium and incubated for 2, 4, 8 or 16 h before harvesting.
Cells were lysed and RNA prepared using the RNeasymini kit (Qiagen)
as described by the manufacturer. Puriﬁed RNA was further treated
with Turbo DNA-free (Ambion) to remove any residual cell DNA. RNA
quality was checked by analysing all samples on an Agilent
Bioanalyser using the RNA 6000 Nano kit, with no samples showing
detectable degradation or DNA contamination. RNA concentration
was measured by Nanodrop.
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1 μg total RNA was ampliﬁed with simultaneous incorporation of
amino-allyl UTP using the Amino Allyl MessageAmp™ II aRNA
ampliﬁcation kit (Ambion) according to the manufacturer's protocol.
The quality of the ampliﬁed RNA (aRNA) was checked using the
Agilent Bioanalyser and quantiﬁed using the Nanodrop. aRNA was
labelled with AlexaFluor 555 or 647 using the succinyl-ester
derivatives (Invitrogen). Each vial of dye was resuspended in 11 μl
DMSO. aRNA (10 μg) was dried and redissolved in 9 μl coupling buffer
(Ambion), added to the dissolved dye and incubated for 30 min at
room temperature. The reaction was quenched by adding 4.5 μl 4 M
hydroxylamine and incubating for a further 15min. The labelled aRNA
was then puriﬁed using the ﬁlter cartridges provided with the
Message Amp II kit, eluting with 30 μl H2O. Dye incorporation was
determined spectrophotometrically using the Nanodrop, and was 1
dye per 20–30 bases.
Microarrays and hybridisation
The arrays used in these studies were the bovine long oligo (BLO)
array and the bovine total leukocyte (BOTL5) array, both obtained
from the Center for Farm Animal Genomics, University of Michigan.
The BLO array consists of approximately 8400 70mers representing
predicted bovine mRNAs spotted in duplicate, plus a number of
bovine control sequences (“housekeeping” genes) spotted multiple
times, as well as negative control spots. The BOTL5 array has cDNAs
representing 1391 bovine genes selected from a bovine leukocyte
library (Coussens and Nobis, 2002), all spotted in duplicate, with
other spots representing negative controls and bovine housekeeping
genes.
Hybridisation was performed in ArrayHyb#3 buffer (Ambion)
using a Hybstation 4800 (Tecan). Each labelled aRNAwas divided into
two; half was used to hybridise to a BLO array and half to a BOTL array.
All aRNAs were cohybridised with other experimental samples in an
interwoven loop design (incomplete block design in which each array
is a block) (Fig. S1 in Supplemental Materials). Samples from the six
experimental animals were randomly allocated to each ‘block’
(cohybridisation) to avoid bias. The resultant two-channel data
from the arrays were normalised using the routines in the LIMMA
package. All raw microarray data and protocols have been deposited
in the Array Express database (http://www.ebi.ac.uk/microarray-as/
ae/) with accession number E-MEXP-1856.
Data analysis
Arrays were scanned on a GenePix 4000B scanner. Segmentation
was performed with SpotFinder (Niles Scientiﬁc Inc) for BLO arrays or
with BlueFuse (BlueGnome) for BOTL arrays. The array data was
normalised (Smyth and Speed, 2003) using the ‘R’ package LIMMA;
control spots were eliminated and duplicate spots averaged before
further analysis. LIMMA was used to ﬁt a linear model to the data in
which dye, animal and treatment (virus/time) were factors. From the
initial linear model, contrasts were extracted comparing virus-
infected with mock-infected at each time or each virus with other
viruses at each time. These contrasts were used to determine the array
features showing differential expression (Smyth, 2004), which were
taken as features where the LIMMA coefﬁcient (ﬁtted value of log2
(fold change in transcription)) was statistically different from 0 at
pb0.05 after adjustment for multiple comparisons. The results of
both sets of contrasts (virus vs mock and virus vs virus) for the BLO
arrays are provided in Supplemental Materials as a Microsoft Excel ﬁle
(BLO array data.xls).
Data from the LIMMA analysis was used for Ingenuity Pathway
Analysis (Ingenuity® Systems, www.ingenuity.com). Normalised two-
colour data were converted back to single-colour data for principalcomponent analysis (PCA) of the data. PCA was performed using the
prcomp() function in ‘R’. Gene Set Expression Analysis was carried out
on the single-colour data using the package GSEA from the Broad
Institute (Mootha et al., 2003; Subramanian et al., 2005) after
mapping the bovine genes represented by each array feature to the
corresponding human homologue where this was known. Functional
module analysis (Marston et al., 2009; Ortega et al., 2008; Sameith et
al., 2008) was performed by summarizing the activity of a gene subset
associated with a given KEGG pathway by computing the ﬁrst two
principal components (PCs). In order to identify PCs which were
associated with differences in the responses of cells infected with
different viruses we applied the SAM statistical test (Tusher et al.,
2001).
Real-time quantitative RT-PCR
For quantiﬁcation of mRNA transcripts, primer pairs were selected
using Primer3 (Rozen and Skaletsky, 2000) based on the relevant
bovine mRNA sequence. RPV N mRNA was quantiﬁed using a primer
pair matching a highly conserved region of the N mRNA and designed
so that the primer annealing sites are identical between the RPV-S and
RPV-R strains. The MV N mRNA was quantiﬁed using the MV multi-
strain primers described in Hummel et al. (2006) and the results
conﬁrmed using the N mRNA primer pair described by El Mubarak et
al. (2005). Optimal annealing temperatures were determined for each
primer pair and the primers checked for absence of primer dimers
before use. The primers used and the optimum annealing temperature
for PCR for each pair are listed in Table I in Supplemental Materials.
Equal amounts of aRNA (80 μg) for each treatment-time combination
were pooled across animals; reverse transcription was carried out on
120 ng of the pooled RNA using anchored oligo(dT) ((dT)16VN) as the
primer and Superscript III (Invitrogen) essentially as described by the
manufacturer. The resultant cDNAs were diluted four-fold and heated
at 70 °C for 15 min. PCR was carried out using JumpStart Sybr Green
mix (Sigma); each reaction contained 2 μl diluted cDNA and 2 pmol
each of the forward and reverse primers. Duplicate PCRs were carried
out from each of duplicate cDNAs. As all the commonly used
housekeeping genes we have examined show some level of change
in response to RPV infection, we relied on accurate measurement of
RNA concentration to ensure comparability of samples.
Acknowledgments
We are very grateful to Dr Paul Coussens and Ms Sue Sipkovsky of
the Center for Farm Animal Genomics at the University of Michigan
for making the bovine microarrays available at cost to the academic
community; without this valuable resource, our work would have
been a great deal more difﬁcult. We express particular thanks to Dr
Paul Duprex and Dr Linda Rennick, Queens' University Belfast, for the
gift of the wild-type measles virus and for the clones of the V and C
protein open reading frames from that isolate. This work was funded
by grants S20213 and S20214 from the Biotechnology and Biological
Sciences Research Council (BBSRC) as well as BBSRC project
BBSEI00001014.
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.virol.2009.09.031.
References
Baron, M.D., 2005. Wild-type rinderpest virus uses SLAM (CD150) as its receptor. J. Gen.
Virol. 86 (Pt 6), 1753–1757.
Baron, M.D., Barrett, T., 1997. Rescue of rinderpest virus from cloned cDNA. J. Virol. 71,
1265–1271.
231S.K. Nanda et al. / Virology 395 (2009) 223–231Bartlett, E.J., Cruz, A.M., Esker, J., Castano, A., Schomacker, H., Surman, S.R., Hennessey,
M., Boonyaratanakornkit, J., Pickles, R.J., Collins, P.L., Murphy, B.R., Schmidt, A.C.,
2008. Human parainﬂuenza virus type 1 C proteins are nonessential proteins that
inhibit the host interferon and apoptotic responses and are required for efﬁcient
replication in nonhuman primates. J. Virol. 82 (18), 8965–8977.
Berghall, H., Siren, J., Sarkar, D., Julkunen, I., Fisher, P.B., Vainionpaa, R., Matikainen, S.,
2006. The interferon-inducible RNA helicase, mda-5, is involved in measles virus-
induced expression of antiviral cytokines. Microbes and Infect. 8 (8), 2138–2144.
Bieback, K., Lien, E., Klagge, I.M., Avota, E., Schneider-Schaulies, J., Duprex, W.P.,
Wagner, H., Kirschning, C.J., ter Meulen, V., Schneider-Schaulies, S., 2002.
Hemagglutinin protein of wild-type measles virus activates toll-like receptor 2
signaling. J. Virol. 76 (17), 8729–8736.
Boxer, E.L., Nanda, S.K., Baron, M.D., 2009. The rinderpest virus non-structural C protein
blocks the induction of type 1 interferon. Virology 385 (1), 134–142.
Brown, D.D., Collins, F.M., Duprex, W.P., Baron, M.D., Barrett, T., Rima, B.K., 2005.
“Rescue” of mini-genomic constructs and viruses by combinations of morbillivirus
N, P and L proteins. J. Gen. Virol. 86, 1077–1081.
Coussens, P.M., Nobis, W., 2002. Bioinformatics and high throughput approach to create
genomic resources for the study of bovine immunobiology. Vet. Immunol.
Immunopathol. 86 (3–4), 229–244.
Devaux, P., Hodge, G., McChesney, M.B., Cattaneo, R., 2008. Attenuation of V- or C-
defective measles viruses: infection control by the inﬂammatory and interferon
responses of rhesus monkeys. J. Virol. 82 (11), 5359–5367.
El Mubarak, H.S., De Swart, R.L., Osterhaus, A.D., Schutten, M., 2005. Development of a
semi-quantitative real-time RT-PCR for the detection of measles virus. J. Clin. Virol.
32 (4), 313–317.
el-Zein, A., Srour, E., 1985. Production of interferon and of plaque enhancing factor by
rinderpest-virus. Zentralbl Veterinarmed B 32 (6), 466–471.
Ghali, M., Schneider-Schaulies, J., 1998. Receptor (CD46)- and replication-mediated
interleukin-6 induction by measles virus in human astrocytoma cells. J. Neurovirol.
4 (5), 521–530.
Gubbay, O., Curran, J., Kolakofsky, D., 2001. Sendai virus genome synthesis and
assembly are coupled: a possible mechanism to promote viral RNA polymerase
processivity. J. Gen. Virol. 82 (Pt. 12), 2895–2903.
Hahm, B., 2009. Hostile communication ofmeasles virus with host innate immunity and
dendritic cells. Curr. Top. Microbiol. Immunol. 330, 271–287.
Huang, Z., Krishnamurthy, S., Panda, A., Samal, S.K., 2003. Newcastle disease virus V
protein is associated with viral pathogenesis and functions as an alpha interferon
antagonist. J. Virol. 77 (16), 8676–8685.
Hummel, K.B., Lowe, L., Bellini, W.J., Rota, P.A., 2006. Development of quantitative gene-
speciﬁc real-time RT-PCR assays for the detection of measles virus in clinical
specimens. J. Virol. Methods 132 (1–2), 166–173.
Hussain, S.F., Akhtar, A.S., Rweyemamu, M.M., Kaminjolo, J.S., Mugera, G.M., 1982.
Studies on viral interference induced by rinderpest virus: 3. Interferon induction by
attenuated and virulent strains of rinderpest virus in tissue culture. Bull. Anim.
Health Prod. Afr. 30 (1), 1–6.
Kelley, R., Feizi, H., Ideker, T., 2008. Correcting for gene-speciﬁc dye bias in DNA
microarrays using the method of maximum likelihood. Bioinformatics 24 (1), 71–77.
Kobune, F., Sakata, H., Sugiyama, M., Sugiura, A., 1991. B95a, a marmoset lympho-
blastoid cell line, as a sensitive host for rinderpest virus. J. Gen. Virol. 72, 687–692.
Kovamees, J., Blixenkrone-Moller, M., Sharma, B., Orvell, C., Norrby, E., 1991. The
nucleotide sequence and deduced amino acid composition of the haemagglutinin
and fusion proteins of the morbillivirus phocid distemper virus. J. Gen. Virol. 72
(Pt. 12), 2959–2966.
Liang, M., Briggs, A.G., Rute, E., Greene, A.S., Cowley Jr, A.W., 2003. Quantitative
assessment of the importance of dye switching and biological replication in cDNA
microarray studies. Physiol. genomics 14 (3), 199–207.
Marston, E., Weston, V., Jesson, J., Maina, E., McConville, C., Agathanggelou, A.,
Skowronska, A., Mapp, K., Sameith, K., Powell, J.E., Lawson, S., Kearns, P., Falciani, F.,
Taylor, M., Stankovic, T., 2009. Stratiﬁcation of pediatric ALL by in vitro cellular
responses to DNA double-strand breaks provides insight into the molecular
mechanisms underlying clinical response. Blood 113 (1), 117–126.
Martin-Magniette, M.L., Aubert, J., Cabannes, E., Daudin, J.J., 2005. Evaluation of the
gene-speciﬁc dye bias in cDNA microarray experiments. Bioinformatics 21 (9),
1995–2000.
Misra, J., Schmitt, W., Hwang, D., Hsiao, L.L., Gullans, S., Stephanopoulos, G., 2002.
Interactive exploration of microarray gene expression patterns in a reduced
dimensional space. Genome Res. 12 (7), 1112–1120.
Mootha, V.K., Lindgren, C.M., Eriksson, K.F., Subramanian, A., Sihag, S., Lehar, J.,
Puigserver, P., Carlsson, E., Ridderstrale, M., Laurila, E., Houstis, N., Daly, M.J.,
Patterson, N., Mesirov, J.P., Golub, T.R., Tamayo, P., Spiegelman, B., Lander, E.S.,
Hirschhorn, J.N., Altshuler, D., Groop, L.C., 2003. PGC-1alpha-responsive genes
involved in oxidative phosphorylation are coordinately downregulated in human
diabetes. Nat. Genet. 34 (3), 267–273.
Murabayashi, N., Kurita-Taniguchi, M., Ayata, M., Matsumoto, M., Ogura, H., Seya, T.,
2002. Susceptibility of human dendritic cells (DCs) to measles virus (MV) dependson their activation stages in conjunction with the level of CDw150: role of Toll
stimulators in DC maturation and MV ampliﬁcation. Microbes and Infect. 4,
785–794.
Nanda, S.K., Baron, M.D., 2006. Rinderpest virus blocks type I and type II interferon
action: role of structural and nonstructural proteins. J. Virol. 80 (15), 7555–7568.
Naniche, D., Yeh, A., Eto, D., Manchester, M., Friedman, R.M., Oldstone, M.B.A., 2000.
Evasion of host defenses by measles virus: wild-type measles virus infection
interferes with the induction of alpha/beta interferon production. J. Virol. 74,
7478–7484.
Norrby, E., Kovamees, J., Blixenkrone-Möller, M., Sharma, B., Orvell, C., 1992.
Humanized animal viruses with special reference to the primate adaptation of
morbillivirus. Vet. Microbiol. 33, 275–286.
Ortega, F., Sameith, K., Turan, N., Compton, R., Trevino, V., Vannucci, M., Falciani, F.,
2008. Models and computational strategies linking physiological response to
molecular networks from large-scale data. Philos. Transact A Math. Phys. Eng. Sci.
366 (1878), 3067–3089.
Parisien, J.P., Lau, J.F., Horvath, C.M., 2002. STAT2 acts as a host range determinant for
species-speciﬁc paramyxovirus interferon antagonism and simian virus 5 replica-
tion. J. Virol. 76 (13), 6435–6441.
Patterson, C.E., Daley, J.K., Echols, L.A., Lane, T.E., Rall, G.F., 2003. Measles virus infection
induces chemokine synthesis by neurons. J. Immunol. 171 (6), 3102–3109.
Plumet, S., Duprex, W.P., Gerlier, D., 2005. Dynamics of viral RNA synthesis during
measles virus infection. J. Virol. 79 (11), 6900–6908.
Plumet, S., Herschke, F., Bourhis, J.M., Valentin, H., Longhi, S., Gerlier, D., 2007. Cytosolic
5′-triphosphate ended viral leader transcript of measles virus as activator of the RIG
I-mediated interferon response. PLoS ONE 2, e279.
Rozen, S., Skaletsky, H., 2000. Primer3 on the WWW for general users and for biologist
programmers. Methods Mol. Biol. 132, 365–386.
Sameith, K., Antczak, P., Marston, E., Turan, N., Maier, D., Stankovic, T., Falciani, F., 2008.
Functional modules integrating essential cellular functions are predictive of the
response of leukaemia cells to DNA damage. Bioinformatics 24 (22), 2602–2607.
Sato, H., Honma, R., Yoneda, M., Miura, R., Tsukiyama-Kohara, K., Ikeda, F., Seki, T.,
Watanabe, S., Kai, C., 2008. Measles virus induces cell-type speciﬁc changes in gene
expression. Virology 375 (2), 321–330.
Seki, F., Ono, N., Yamaguchi, R., Yanagi, Y., 2003. Efﬁcient isolation of wild strains of
canine distemper virus in Vero cells expressing canine SLAM (CD150) and their
adaptability to marmoset B95a cells. J. Virol. 77 (18), 9943–9950.
Shingai, M., Ebihara, T., Begum, N.A., Kato, A., Honma, T., Matsumoto, K., Saito, H., Ogura,
H., Matsumoto, M., Seya, T., 2007. Differential type I IFN-inducing abilities of wild-
type versus vaccine strains of measles virus. J. Immunol. 179 (9), 6123–6133.
Smyth, G.K., 2004. Linear models and empirical bayes methods for assessing differential
expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3 Article3.
Smyth, G.K., Speed, T., 2003. Normalization of cDNA microarray data. Methods (San
Diego, Calif 31 (4), 265–273.
Subramanian, A., Tamayo, P., Mootha, V.K., Mukherjee, S., Ebert, B.L., Gillette, M.A.,
Paulovich, A., Pomeroy, S.L., Golub, T.R., Lander, E.S., Mesirov, J.P., 2005. Gene set
enrichment analysis: a knowledge-based approach for interpreting genome-wide
expression proﬁles. Proc. Natl. Acad. Sci. U. S. A. 102 (43), 15545–15550.
Takeuchi, K., Miyajima, N., Nagata, N., Takeda, M., Tashiro, M., 2003. Wild-type measles
virus induces large syncytium formation in primary human small airway epithelial
cells by a SLAM(CD150)-independent mechanism. Virus Res. 94 (1), 11–16.
Tatsuo, H., Ono, N., Yanagi, Y., 2001. Morbilliviruses use signaling lymphocyte activation
molecules (CD150) as cellular receptors. J. Virol. 75 (13), 5842–5850.
Trepanier, P., Payment, P., Trudel, M., 1981. Concentration of human respiratory
syncytial virus using ammonium sulfate, polyethylene glycol or hollow ﬁber
ultraﬁltration. J. Virol. Methods 3 (4), 201–211.
Tusher, V.G., Tibshirani, R., Chu, G., 2001. Signiﬁcance analysis of microarrays applied to
the ionizing radiation response. Proc. Natl. Acad. Sci. U. S. A. 98, 5116–5121.
Wang, Y., Barbacioru, C., Hyland, F., Xiao, W., Hunkapiller, K.L., Blake, J., Chan, F.,
Gonzalez, C., Zhang, L., Samaha, R.R., 2006. Large scale real-time PCR validation on
gene expression measurements from two commercial long-oligonucleotide
microarrays. BMC Genomics 7, 59.
Werling, D., Hope, J.C., Chaplin, P., Collins, R.A., Taylor, G., Howard, C.J., 1999.
Involvement of caveolae in the uptake of respiratory syncitial virus antigen by
dendritic cells. J. Leukoc. Biol. 66, 50–58.
Whistler, T., Bellini, W.J., Rota, P.A., 1996. Generation of defective interfering particles
by two vaccine strains of measles virus. Virology 220 (2), 480–484.
Yamanouchi, K., Chino, F., Kobune, F., Fukuda, A., Yoshikawa, Y., 1974. Pathogenesis of
rinderpest virus infection in rabbits I. Clinical signs, immune response, histological
changes, and virus growth patterns. Infect. Immun. 9, 199–205.
Yuen, T., Wurmbach, E., Pfeffer, R.L., Ebersole, B.J., Sealfon, S.C., 2002. Accuracy and
calibration of commercial oligonucleotide and custom cDNA microarrays. Nucleic
Acids Res. 30 (10), e48.
Zilliox, M.J., Parmigiani, G., Grifﬁn, D.E., 2006. Gene expression patterns in dendritic
cells infected with measles virus compared with other pathogens. Proc. Natl. Acad.
Sci. U. S. A. 103 (9), 3363–3368.
